Genetic markers in acquired haemophilia

Haemophilia

Volumn 16, Issue SUPPL. 3, 2010, Pages 41-45

  Oldenburg, J ^a   Zeitler, H ^b   Pavlova, A ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Acquired haemophilia; CTLA 4; HLA class I; HLA class II; Polymorphisms

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; CD40 ANTIGEN; CD40 LIGAND; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; AUTOIMMUNITY; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HEMOPHILIA; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION;

ALLELES; ANTIGENS, CD; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEMOPHILIA A; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77953532472     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02259.x     Document Type: Review

References (33)

1. Giangrande P. Acquired hemophilia. Treatment of Hemophilia 2005, 38:1-8. http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/TOH38_Acquired_Hemophilia.pdf, Available at Accessed October 2009
2. Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol 2005, 80:55-63.
3. Huth-Kühne A, Baudo F, Collins P. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009, 94:566-75.
4. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981, 45:200-3.
5. Bossi P, Cabane J, Ninet J. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998, 105:400-8.
6. Collins PW, Hirsch S, Baglin TP. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007, 109:1870-7.
7. Pavlova A, Diaz-Lacava A, Zeitler H. Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls. Haemophila 2008, 14:355-60.
8. Pavlova A, Zeitler H, Scharrer I, Brackmann H-H, Oldenburg J. HLA genotype in patients with acquired haemophilia A. Haemophilia 2010, 16(3).
9. Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006, 12:90-8.
10. Mackay IR. Science, medicine, and the future: tolerance and autoimmunity. BMJ 2000, 321:93-6.
11. Perkins D, Wang Z, Donovan C. Regulation of CTLA-4 expression during T cell activation. J Immunol 1996, 156:4154-9.
12. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991, 147:1037-44.
13. Takahashi T, Tagami T, Yamazaki S. Immunologic self-tolerance maintained by CD25+ CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000, 192:303-10.
14. Eagar TN, Karandikar NJ, Bluestone JA, Miller SD. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol 2002, 32:972-81.
15. http://www.ncbi.nlm.nih.gov/projects/gv/mhc/main.fcgi?cmd=init, Available at Accessed October 2009
16. Nelson JL, Hansen JA. Autoimmune diseases and HLA. Crit Rev Immunol 1990, 10:307-28.
17. Reveille JD. The genetic basis of autoantibody production. Autoimmun Rev 2006, 5:389-98.
18. Morran MP, Omenn GS, Pietropaolo M. Immunology and genetics of type 1 diabetes. Mt Sinai J Med 2008, 75:314-27.
19. Harbo HF, Lie BA, Sawcer S. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004, 63:237-47.
20. Forabosco P, Gorman JD, Cleveland C. Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun 2006, 7:609-14.
21. Jawaheer D, Li W, Graham RR. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002, 71:585-94.
22. Oldenburg J, Picard JK, Schwaab R, Brackmann HH, Tuddenham EG, Simpson E. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thromb Haemost 1997, 77:238-42.
23. Pavlova A, Delev D, Lacroix-Desmazes S. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A. J Thromb Haemost 2009, 7:2006-15.
24. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993, 178:27-47.
25. Dariavach P, Mattéi MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA- 4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988, 18:1901-5.
26. Deichmann K, Heinzmann A, Brüggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem Biophys Res Commun 1996, 225:817-8.
27. Donner H, Rau H, Walfish PG. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997, 82:143-6.
28. Ueda H, Howson JM, Esposito L. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-11.
29. Kouki T, Sawai Y, Gardine CA, Fisfalen M-E, Alegre M-L, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' Disease. J Immunol 2000, 165:6606-11.
30. Suppiah V, O'Doherty C, Heggarty S, Patterson CC, Rooney M, Vandenbroeck K. The CTLA4 + 49A/G and CT60 polymorphisms and chronic inflammatory athropathies in Northern Ireland. Exp Mol Pathol 2006, 80:141-6.
31. Yeşilkaya E, Koç A, Bideci A. CTLA4 gene polymorphisms in children and adolescents in autoimmune thyroid diseases. Genet Test 2008, 12:461-4.
32. Sahin M, Gursoy A, Erdogan MF. Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis. Int J Immunogenet 2009, 36:103-6.
33. Astermark J, Wang X, Oldenburg J, Berntorp E, Lefvert A-K. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A. J Thromb Haemost 2007, 5:263-5.